HEALTHCARE RESOURCE UTILIZATION AND COST BURDEN OF FACIAL ANGIOFIBROMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: A REAL-WORLD CLAIMS DATABASE ANALYSIS IN THE UNITED STATES

被引：0
|
作者：
Hebert, A. A. [1 ]
Paydar, C. [2 ]
Das, A. K. [2 ]
Boggarapu, S. [3 ]
Beresford, E. [3 ]
机构：
[1] UT Hlth McGovern Med Sch, Houston, TX USA
[2] Partnership Hlth Analyt Res PHAR LLC, Beverly Hills, CA USA
[3] Nobelpharma Amer LLC, Bethesda, MD USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE407
引用
收藏
页码：S134 / S134
页数：1
相关论文
共 50 条
  • [1] Real-World Healthcare Resource Utilization and Cost Burden Assessment for Adults With Generalized Myasthenia Gravis in the United States
    Phillips, Glenn
    Abreu, Catarina
    Goyal, Amit
    Li, Yuebing
    Whangbo, Albert
    Gelinas, Deborah
    Brauer, Edward
    Bhattacharya, Sankha
    FRONTIERS IN NEUROLOGY, 2022, 12
  • [2] TOPICAL SIROLIMUS 0.2% GEL FOR FACIAL ANGIOFIBROMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX IN THE UNITED STATES: A COST-EFFECTIVENESS ANALYSIS
    Dutta, S.
    Teng, J.
    Bhattacharyya, S.
    John, D.
    Boggarapu, S.
    Beresford, E.
    VALUE IN HEALTH, 2023, 26 (06) : S155 - S156
  • [3] Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database
    Sreedevi Boggarapu
    Steven L. Roberds
    JoAnne Nakagawa
    Eric Beresford
    Orphanet Journal of Rare Diseases, 17
  • [4] Characterization and management of facial angiofibroma related to tuberous sclerosis complex in the United States: retrospective analysis of the natural history database
    Boggarapu, Sreedevi
    Roberds, Steven L.
    Nakagawa, JoAnne
    Beresford, Eric
    ORPHANET JOURNAL OF RARE DISEASES, 2022, 17 (01)
  • [5] Real-world treatment profile for patients with tuberous sclerosis complex related angiomyolipoma: A US Healthcare Claims Database study
    Sun, Peter
    Liu, Zhimei
    Kohrman, Michael
    Bissler, John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [6] Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study
    Tepper, S. J.
    Schwedt, T. J.
    Vo, P.
    Joshi, P.
    Glassberg, M.
    Abdrabboh, A.
    Ferraris, M.
    Tiwari, S.
    Thompson, J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 26 - 26
  • [7] Real-world healthcare costs and resource utilization (HRU) among patients treated with erenumab in the United States: A retrospective claims database study
    Tepper, S. J.
    Schwedt, T. J.
    Vo, P.
    Joshi, P.
    Glassberg, M.
    Abdrabboh, A.
    Ferraris, M.
    Tiwari, S.
    Thompson, J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 17 - 18
  • [8] BURDEN OF ILLNESS IN PATIENTS WITH FACIAL ANGIOFIBROMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX: A SYSTEMATIC REVIEW
    John, D.
    Schachner, L. A.
    Hebert, A. A.
    Rai, D.
    Majumdar, Dutta A.
    Boggarapu, S.
    Beresford, E.
    VALUE IN HEALTH, 2023, 26 (06) : S270 - S270
  • [9] A REAL-WORLD CLAIMS ANALYSIS OF GLIOBLASTOMA COST OF CARE IN THE UNITED STATES
    Norden, A.
    You, M.
    Dastani, H.
    Bobiak, S.
    Korytowsky, B.
    Singh, P.
    VALUE IN HEALTH, 2017, 20 (05) : A360 - A360
  • [10] TOPICAL SIROLIMUS 0.2% GEL FOR TREATMENT OF FACIAL ANGIOFIBROMA ASSOCIATED WITH TUBEROUS SCLEROSIS COMPLEX IN THE UNITED STATES: A BUDGET IMPACT ANALYSIS
    Thomas, A.
    Hebert, A. A.
    Bhattacharyya, S.
    Boggarapu, S.
    Beresford, E.
    VALUE IN HEALTH, 2023, 26 (06) : S91 - S91
12345